|
|
|
|
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc.(NASDAQ:CADX) announced today that Scott Byrd has joined the company as Senior Vice President and Chief Commercial Officer. Byrd will report directly to Ted...
|
|
|
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
SAN DIEGO, June 22 (HSMN NewsFeed) -- Cadence Pharmaceuticals, Inc.(Nasdaq: CADX ) announced today that Scott Byrd has joined the company as Senior Vice President and Chief Commercial Officer. Byrd will report directly to Ted Schroeder,...
|
|
|
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
Press Release Source: Cadence Pharmaceuticals, Inc.On Monday June 22, 2009, 8:00 am EDT SAN DIEGO, June 22 /PRwire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: - ) announced today that Scott Byrd has joined the company as Senior...
|
|
|
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc.announced today that Scott Byrd has joined the company as Senior Vice President and Chief Commercial Officer. Byrd will report directly to Ted Schroeder,...
|
|
|
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc.(Nasdaq: CADX) announced today that Scott Byrd has joined the company as Senior Vice President and Chief Commercial Officer. Byrd will report directly to Ted...
|
|
|
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc.announced today that Scott Byrd has joined the company as Senior Vice President and Chief Commercial Officer. Byrd will report directly to Ted Schroeder,...
|
|
|
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc.(Nasdaq: CADX) announced today that Scott Byrd has joined the company as Senior Vice President and Chief Commercial Officer. Byrd will report directly to Ted...
|
|
|
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc.(Nasdaq: CADX) announced today that Scott Byrd has joined the company as Senior Vice President and Chief Commercial Officer. Byrd will report directly to Ted...
|
|
|
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc.(Nasdaq: CADX) announced today that Scott Byrd has joined the company as Senior Vice President and Chief Commercial Officer. Byrd will report directly to Ted...
|
|
|
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc.(NASDAQ:CADX) announced today that Scott Byrd has joined the company as Senior Vice President and Chief Commercial Officer. Byrd will report directly to Ted...
|
|
|
Accumetrics, Inc. Announces Distribution Channels in Israel and Cyprus
SAN DIEGO The VerifyNow System assesses response to antiplatelet therapies, such as aspirin, Plavix(R) and GP IIb/IIIa inhibitors.As response to these drugs varies, the tests help physicians ensure their patients on antiplatelet...
|
|
|
Silver Nanoparticles Show 'Immense Potential' In Prevention Of Blood Clots, Banaras Hindu University Study
' Scientists are reporting discovery of a potential new alternative to aspirin, ReoPro, and other anti-platelet agents used widely to prevent blood clots in coronary artery disease, heart attack and stroke.Silver Nanoparticles Show ...
|
|
|
Silver Nanoparticles Show 'immense Potential' In Prevention Of Blood Clots
Scientists are reporting discovery of a potential new alternative to aspirin, ReoPro, and other anti-platelet agents used widely to prevent blood clots in coronary artery disease, heart attack and stroke.Their study, scheduled for...
|
|
|
Silver Nanoparticles Show 'immense Potential' In Prevention Of Blood Clots
Scientists are reporting discovery of a potential new alternative to aspirin, ReoPro, and other anti-platelet agents used widely to prevent blood clots in coronary artery disease, heart attack and stroke.Their study, scheduled for...
|
